Cargando…

Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies

The development of prevention therapies for Alzheimer's disease (AD) would greatly benefit from biomarkers that are sensitive to the subtle brain changes that occur in the preclinical stage of the disease. Reductions in the cerebral metabolic rate of glucose (CMRglc), a measure of neuronal func...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mistur, Rachel, Mosconi, Lisa, Santi, Susan De, Guzman, Marla, Li, Yi, Tsui, Wai, de Leon, Mony J.
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806537/ https://www.ncbi.nlm.nih.gov/pubmed/20076796 http://dx.doi.org/10.3988/jcn.2009.5.4.153

Ejemplares similares

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2008)

Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study
por: Matthews, Dawn C., et al.
Publicado: (2014)

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2022)

Maternal transmission of Alzheimer's disease: Prodromal metabolic phenotype and the search for genes
por: Mosconi, Lisa, et al.
Publicado: (2010)

Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study
por: Mosconi, Lisa, et al.
Publicado: (2014)

Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study
por: Mosconi, Lisa, et al.
Publicado: (2018)

Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery
por: Mosconi, Lisa, et al.
Publicado: (2017)

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
por: Fossati, Silvia, et al.
Publicado: (2019)

Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery
por: Mosconi, Lisa, et al.
Publicado: (2018)

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease
por: Murray, John, et al.
Publicado: (2014)

Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
por: Contador, José, et al.
Publicado: (2021)

Sleep oscillation-specific associations with Alzheimer’s disease CSF biomarkers: novel roles for sleep spindles and tau
por: Kam, Korey, et al.
Publicado: (2019)

Current Biomarkers for Alzheimer’s Disease: From CSF to Blood
por: Zou, Kun, et al.
Publicado: (2020)

Betahydroxybutyrate Consumption in Autopsy Brain Tissue from Alzheimer’s Disease Subjects
por: Swerdlow, Russell H., et al.
Publicado: (2021)

Associations of lifestyle and vascular risk factors with Alzheimer’s brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area
por: Walters, Michelle J, et al.
Publicado: (2018)

The Alzheimer's Imaging Consortium: Celebrating 20 years of creativity and progress
por: de Leon, Mony J.
Publicado: (2016)

CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer’s Disease
por: Lee, Sarah, et al.
Publicado: (2013)

Resting-State Glucose Metabolism Level Is Associated with the Regional Pattern of Amyloid Pathology in Alzheimer's Disease
por: Shin, Jonghan, et al.
Publicado: (2011)

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
por: Ramos-Cejudo, Jaime, et al.
Publicado: (2018)

Brain alterations in the early Alzheimer’s continuum with amyloid-β, tau, glial and neurodegeneration CSF markers
por: Salvadó, Gemma, et al.
Publicado: (2022)

CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade
por: Yang, Xianfeng, et al.
Publicado: (2012)

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2018)

CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
por: Hu, William T., et al.
Publicado: (2016)

CSF p-tau231: A biomarker for early preclinical Alzheimer?
por: Suárez-Calvet, Marc
Publicado: (2022)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging
por: Wadghiri, Youssef Zaim, et al.
Publicado: (2013)

Challenges associated with biomarker-based classification systems for Alzheimer's disease
por: Illán-Gala, Ignacio, et al.
Publicado: (2018)

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
por: Geijselaers, Stefan L.C., et al.
Publicado: (2017)

Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease
por: Kant, Shawn, et al.
Publicado: (2018)

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease
por: Miners, James, et al.
Publicado: (2023)

CSF Biomarkers for Alzheimer's Disease Diagnosis
por: Anoop, A., et al.
Publicado: (2010)

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
por: Palmqvist, Sebastian, et al.
Publicado: (2015)

CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease
por: Teuber-Hanselmann, Sarah, et al.
Publicado: (2020)

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
por: Whelan, Christopher D., et al.
Publicado: (2019)

CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
por: Dong, Ruocheng, et al.
Publicado: (2021)

Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects
por: Glodzik, Lidia, et al.
Publicado: (2016)

The Sincerest Form of Flattery: Nationalist Emulation during the COVID-19 Pandemic
por: Givens, John Wagner, et al.
Publicado: (2020)

Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer’s disease: a cross-sectional study of middle-aged adults from the broader New York City area
por: Mosconi, Lisa, et al.
Publicado: (2018)

Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer’s disease
por: Maioli, Silvia, et al.
Publicado: (2015)

Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
por: Alcolea, Daniel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_an32qvrat7mhj5g70v9g7psn9m